News

Vallourec Voting Rights Report: Total Shares Overview

Vallourec Voting Rights Report: Total Shares Overview

Overview of Vallourec's Voting Rights Information

VALLOUREC
French limited liability company (société anonyme) with a Board of Directors
with share capital of € 4,761,692.46
Registered office: 12, rue de la Verrerie – 92190 Meudon, France
Registered on the Nanterre Trade and Companies Register under n° 552 142 200

Monthly Information on Voting Rights
This month, we provide an update regarding the total number of voting rights associated with Vallourec shares. This information is essential for shareholders, investors, and stakeholders tracking the company's governance structures.

Understanding Voting Rights and Shares

According to Article L. 233-8-II of the French Code de commerce and Article 223-16 of the General Regulations of the Autorité des Marchés Financiers (AMF), a detailed examination of voting rights is essential. The theoretical total number of voting rights comprises all shares with voting rights, including treasury shares that may have their voting rights temporarily suspended.

Current Figures on Outstanding Shares

The table below outlines the total number of outstanding shares alongside the theoretical and net total number of voting rights for the most recent months:

Date Total Number of Outstanding Shares Theoretical Total Number of Voting Rights Net Total Number of Voting Rights
31 January 2025 238,084,623 233,966,259 233,966,259
31 December 2024 238,084,623 233,917,225 233,917,225
30 November 2024 238,052,129 231,123,100 231,123,100
31 October 2024 238,052,129 231,051,893 231,051,893
30 September 2024 237,784,309 230,304,541 230,304,541
31 August 2024 237,784,309 230,244,702 230,244,702
31 July 2024 237,784,309 229,947,719 229,947,719
30 June 2024 237,271,828 229,877,070 229,769,402
31 May 2024 237,271,828 229,877,070 229,769,402
30 April 2024 237,271,828 229,877,070 229,769,402

Key Definitions

(1) Theoretical voting rights include all shares with voting rights, which may comprise temporarily disabled shares from voting.

(2) The net number of voting rights calculates rights exercised at shareholder meetings, excluding shares without voting power.

Importance of Voting Rights

Having clear insights into the voting rights associated with your shares is crucial for shareholders. These statistics assist in effective decision-making during AGMs and other corporate voting events.

Additional Information on Vallourec

Vallourec's by-laws mandate that shareholders declare their crossing thresholds, enhancing transparency. This provision aims to foster a more participatory and accountable atmosphere between shareholders and the board, which can significantly influence company strategies and governance.

This information can be accessed on Vallourec's official platform under the “Regulated Information” section, ensuring all stakeholders have the latest updates.

Frequently Asked Questions

What is the significance of voting rights in Vallourec?

Voting rights allow shareholders to participate in decisions that impact the company’s direction and policies, showcasing their influence on management decisions.

How often is the voting rights information updated?

Vallourec updates its voting rights information monthly to provide transparency and keep shareholders informed about their stakes.

Where can I find further regulated information about Vallourec?

Further regulated information can be found on Vallourec’s official website in the ‘Regulated Information’ section.

What do theoretical and net voting rights represent?

Theoretical rights encompass all shares capable of voting, while net rights exclude shares without voting capabilities, focusing solely on those exercisable during meetings.

Why does Vallourec require communication of crossing thresholds?

This requirement ensures accountability among shareholders and fosters greater communication regarding ownership changes that may affect corporate governance.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 16

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 36

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Millrose Faces Securities Fraud Suit Amidst Decline

Updated Category News Views 148

Dark Clouds Over Millrose Properties Holy smokes, folks, if Millrose Properties thought it could skirt under the radar, they were dead wrong. The curtain's been peeled back, and what do we see? A mess of securities fraud allegations and financial hiccups that’s driving its shareholders mad. October wasn’t too friendly—Hunterbrook Media dropped a bombshell revealing...

Continue Reading
John Wong's Decade as Estate Planning Specialist

Updated Category News Views 68

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
SLM Faces Legal Scrutiny as Losses Mount Amid Pause

Updated Category News Views 115

SLM's Latest Troubles: Legal and Financial Impact Ah, student loans—not just a headache for borrowers but now for lenders too. SLM Corporation, that name we know all too well in the student debt circus, has hit a snag. They've paused most of their third-party recovery activities. Let's dig in: net charge-offs for SLM in the third quarter shot up to a hefty $90.4...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 210

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 198

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Tony Perkins' Church Tour amid Controversial Vote

Updated Category News Views 89

Lining the pews in Missouri and Kansas, folks are about to get a powerful dose of Tony Perkins this weekend. The Family Research Council President is driving straight into the heart of both spiritual and political fervor at a couple of church stops on Sunday, October 25—right on the doorstep of a crucial vote in Missouri. Taking the Stage in a Time of Tension Now,...

Continue Reading

Top 5 Most Recently Viewed Articles

Emerging Trends in the Quantum Key Distribution Sector

Updated Category News Views 357

Overview of Quantum Key Distribution Growth The global Quantum Key Distribution (QKD) market is poised for significant growth. Analysts anticipate that the market will expand from USD 0.48 billion in 2024 to USD 2.63 billion by 2030, representing a remarkable Compound Annual Growth Rate (CAGR) of 32.6%. This forecast underscores the urgency for organizations to bolster...

Continue Reading
Understanding the Growing Cloud Endpoint Protection Market

Updated Category News Views 170

In 2023, the cloud endpoint protection market stood at about USD 5.1 billion, but oh boy, was that just the start of a massive wave. Fast forward to projections for 2033, and we’re talking around USD 23.6 billion—a staggering compound annual growth rate (CAGR) of roughly 22.7%. What does this tell us? The need for robust endpoint protection ain't slowing down anytime...

Continue Reading
Hartford HealthCare Cancer Institute Achieves MSK Care Partner Status

Updated Category News Views 129

Historic Milestone in Cancer Care Hartford HealthCare Cancer Institute has made a remarkable achievement by becoming the first healthcare system in the United States to be designated as a Care Partner of Memorial Sloan Kettering Cancer Center (MSK). This prestigious recognition highlights Hartford HealthCare's commitment to providing exceptional oncology care and elevates...

Continue Reading
Actinogen Advances with New Drug Name for Alzheimer's Treatment

Updated Category News Views 330

Actinogen Medical Introduces Emestedastat for Xanamem Actinogen Medical Limited (ASX: ACW) has announced a significant milestone in its Alzheimer's treatment journey with the introduction of the nonproprietary name 'emestedastat' for its leading drug, Xanamem. This recognition by the World Health Organization (WHO) places Actinogen at the forefront of clinical innovation...

Continue Reading
Gilead Sciences Insider Moves Spark Investor Interest

Updated Category News Views 146

Insider Activity at Gilead Sciences: Key Updates Recently, a significant transaction was reported by Jeffrey Bluestone, a Board Member at Gilead Sciences (NASDAQ: GILD). In a filing with the SEC, it was revealed that Bluestone exercised stock options for a total of 5,000 shares. This transaction was valued at $296,250, drawing important attention from investors and market...

Continue Reading